Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis

Pierre Jésus (1, 2) , Philippe Fayemendy (1, 2) , Marie Nicol (2, 3) , Géraldine Lautrette (3) , Huguette Sourisseau (1) , Pierre-Marie Preux (4, 2, 5) , Jean-Claude Desport (1, 2) , Benoît Marin (2, 4, 5) , Philippe Couratier (2, 3)

1 Service d'Hépato-gastro-entérologie et Nutrition [CHU Dupuytren 1, Limoges]
2 NET - Neuroépidémiologie Tropicale
3 Service de Neurologie [CHU Limoges]
4 SIME - Service de l'Information Médicale et de l'Évaluation [CHU Limoges]
5 Laboratoire de Biostatistique et d'Informatique Médicale

The aim of this study was to investigate in ALS patients in order to determine their nutritional, neurological and respiratory parameters and their survival according to the metabolic level.

Mots clés: hypermetabolism; nutritional status; Prognosis; Amyotrophic lateral sclerosis; Survival

Domaines: Santé publique et épidémiologie

Pierre Jésus, Philippe Fayemendy, Marie Nicol, Géraldine Lautrette, Huguette Sourisseau, et al.. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. European Journal of Neurology, 2018, 25 (1), pp.97-104. ⟨10.1111/ene.13468⟩. ⟨hal-01599533⟩